Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer harboring uncommon EGFR mutations: Focus on afatinib
収録刊行物
-
- Seminars in Oncology
-
Seminars in Oncology 46 (3), 271-283, 2019-06
Elsevier BV